Variant report
Variant | nsv1025222 |
---|---|
Chromosome Location | chr9:1497943-1518792 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:1492000..1494748-chr9:1498884..1501267,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4741434 | chr9:1497943-1497944 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs145039379 | chr9:1497956-1497957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs534051528 | chr9:1497961-1497962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568379841 | chr9:1497973-1497974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10810284 | chr9:1497975-1497976 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs573553288 | chr9:1497994-1497995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs181670492 | chr9:1498012-1498013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7019100 | chr9:1498019-1498020 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs186805374 | chr9:1498039-1498040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189299569 | chr9:1498041-1498042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181927879 | chr9:1498050-1498051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527897210 | chr9:1498059-1498060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541686064 | chr9:1498112-1498113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561403564 | chr9:1498122-1498123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530452268 | chr9:1498142-1498143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186569464 | chr9:1498167-1498168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189795019 | chr9:1498208-1498209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577149484 | chr9:1498209-1498210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182695173 | chr9:1498214-1498215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532604953 | chr9:1498251-1498252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552398308 | chr9:1498253-1498254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571384807 | chr9:1498267-1498268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539604506 | chr9:1498316-1498317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs112209221 | chr9:1498325-1498326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553961116 | chr9:1498374-1498375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186415187 | chr9:1498413-1498414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs77857665 | chr9:1498414-1498415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115200498 | chr9:1498419-1498420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs191247239 | chr9:1498430-1498431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541872881 | chr9:1498478-1498479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs561704446 | chr9:1498481-1498482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535192460 | chr9:1498482-1498483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs538314372 | chr9:1498486-1498487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34955750 | chr9:1498505-1498506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573555019 | chr9:1498522-1498523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572135680 | chr9:1498539-1498540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541252346 | chr9:1498549-1498550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs62534836 | chr9:1498558-1498559 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs572326645 | chr9:1498563-1498564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs368713468 | chr9:1498566-1498567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs201188176 | chr9:1498574-1498575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs575206799 | chr9:1498578-1498579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544131368 | chr9:1498592-1498593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34306037 | chr9:1498597-1498598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563634137 | chr9:1498610-1498611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532564350 | chr9:1498616-1498617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs552610854 | chr9:1498627-1498628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537808871 | chr9:1498647-1498648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs559571418 | chr9:1498683-1498684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564433766 | chr9:1498687-1498688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:1491000-1504000 | Weak transcription | Adipose Nuclei | Adipose |
2 | chr9:1504000-1504800 | Strong transcription | Adipose Nuclei | Adipose |
3 | chr9:1504800-1513800 | Weak transcription | Adipose Nuclei | Adipose |
4 | chr9:1511000-1511200 | Enhancers | NHEK | skin |
5 | chr9:1512600-1513000 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr9:1512800-1514200 | Enhancers | NHEK | skin |
7 | chr9:1513000-1513400 | Weak transcription | Fetal Muscle Leg | muscle |
8 | chr9:1513000-1513800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr9:1513200-1514000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr9:1513400-1514800 | Enhancers | Fetal Muscle Leg | muscle |
11 | chr9:1513800-1514600 | Enhancers | Adipose Nuclei | Adipose |
12 | chr9:1514000-1514800 | Enhancers | Psoas Muscle | Psoas |
13 | chr9:1514400-1515000 | Enhancers | Fetal Stomach | stomach |
14 | chr9:1514400-1515800 | Enhancers | GM12878-XiMat | blood |
15 | chr9:1514600-1522600 | Weak transcription | Adipose Nuclei | Adipose |
16 | chr9:1514800-1521600 | Weak transcription | Fetal Muscle Leg | muscle |
17 | chr9:1515000-1515600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
18 | chr9:1515600-1516000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
19 | chr9:1515600-1516000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
20 | chr9:1515600-1516000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
21 | chr9:1515800-1516200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |